No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) ZRSR2 Antibodies:
anti-Rat (Rattus) ZRSR2 Antibodies:
anti-Human ZRSR2 Antibodies:
Go to our pre-filtered search.
This meta-analysis indicates a positive effect of SF3B1 and an adverse prognostic effect of SRSF2, U2AF1, and ZRSR2 mutations in patients with myelodysplastic syndrome.
We conclude that the common clinical features of patients with an isolated mutation of ZRSR2 are a macrocytic anemia without leukopenia, thrombocytopenia or an increase in marrow blast percentage
ZRSR2 has a role in RNA splicing; dysregulated splicing of U12-type introns is a characteristic feature of ZRSR2 mutations in myelodysplastic syndrome
The mutational status of the SRSF2, U2AF1 and ZRSR2 did not affect the response rate or survival in MDS patients who had received first-line decitabine treatment.
In univariate analysis, mutated SRSF2 predicted shorter overall survival and more frequent acute myeloid leukemia progression compared with wild-type SRSF2, whereas mutated U2AF1, ZRSR2 had no impact on patient outcome.
Data show that through recognition of a common splicing element, Urp facilitates distinct steps of U2- and U12-type intron splicing.
This gene encodes an essential splicing factor. The encoded protein associates with the U2 auxiliary factor heterodimer, which is required for the recognition of a functional 3' splice site in pre-mRNA splicing, and may play a role in network interactions during spliceosome assembly.
zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2
, U2 small nuclear RNA auxiliary factor 1-like 2
, U2 small nuclear ribonucleoprotein auxiliary factor (U2AF), 35 kDa, related sequence 2
, U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2
, U2(RNU2) small nuclear RNA auxiliary factor 1-like 2
, U2AF35-related protein
, U2 small nuclear ribonucleoprotein auxiliary factor, small subunit 2
, renal carcinoma antigen NY-REN-20